Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging

Quantitative measurements of regional and tissue specific concentrations of brain metabolites were measured in elderly subjects using multislice proton magnetic resonance spectroscopic imaging (1H MRSI). Selective k‐space extrapolation and an inversion‐recovery sequence were used to minimize lipid contamination and linear regression was used to account for partial volume problems. The technique was applied to measure the concentrations of N‐acetyl aspartate (NAA), and creatine (Cr)‐ and choline (Cho)‐containing compounds in cortical gray and white matter, and white matter lesions of the frontal and the parietal lobe in 40 normal elderly subjects (22 females and 18 males, 56–89 years old, mean age 74 ± 8). NAA was about 15% lower in cortical gray matter and 23% lower in white matter lesions when compared to normal white matter. Cr was 11% higher in cortical gray matter than in white matter, and also about 15% higher in the parietal cortex than in the frontal cortex. Cho was 28% lower in cortical gray matter than in white matter. Furthermore, NAA and Cr changes correlated with age. In conclusion, regional and tissue differences of brain metabolites must be considered in addition to age‐related changes when interpreting 1H MRSI data. Magn Reson Med 45:899–907, 2001. © 2001 Wiley‐Liss, Inc.

[1]  P. Narayana,et al.  Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain , 1995, Magnetic resonance in medicine.

[2]  Gioacchino Tedeschi,et al.  MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain , 1999, Magnetic resonance in medicine.

[3]  A Macovski,et al.  1H spectroscopic imaging using a spectral‐spatial excitation pulse , 1991, Magnetic resonance in medicine.

[4]  G. Fein,et al.  H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. , 1995, Radiology.

[5]  G. Fein,et al.  Tissue segmentation of the brain in Alzheimer disease. , 1997, AJNR. American journal of neuroradiology.

[6]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[7]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[8]  Jullie W Pan,et al.  Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.

[9]  V. Govindaraju,et al.  Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.

[10]  N. Schuff,et al.  Removal of lipid artifacts in 1H spectroscopic imaging by data extrapolation , 1996, Magnetic resonance in medicine.

[11]  O. Petroff,et al.  Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. , 1995, Magnetic resonance imaging.

[12]  Thomas H. Mareci,et al.  Essential considerations for spectral localization using indirect gradient encoding of spatial information , 1991 .

[13]  J. Frahm,et al.  Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS , 1997, NMR in biomedicine.

[14]  J. Duyn,et al.  Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.

[15]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[16]  G J Barker,et al.  A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. , 2000, Magnetic resonance imaging.

[17]  Shi-Jiang Li,et al.  Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.

[18]  Jens Frahm,et al.  Multiple chemical-shift-selective NMR imaging using stimulated echoes , 1985 .

[19]  J Star-Lack,et al.  High spatial resolution 1H‐MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain , 1999, Magnetic resonance in medicine.

[20]  J. Alger,et al.  High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy , 1989, Neurology.

[21]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[22]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[23]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[24]  K. Krishnan,et al.  Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  R. Gruetter,et al.  In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. , 1997, Biophysical chemistry.

[26]  G J Barker,et al.  Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.

[27]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[28]  J R Griffiths,et al.  Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[29]  K. Lim,et al.  Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.